GRIFOLS | GRF - Current Assets


GRIFOLS reported EUR5.25B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alcon AG USD 6.62B 171M Mar/2026
Almirall EUR 713.98M 69K Dec/2025
Amadeus IT EUR 2.32B 162.6M Mar/2026
Amarin USD 626.02M 23.87M Mar/2026
argenx SE USD 6.9B 1.07B Dec/2025
AstraZeneca USD 29.61B 890M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Cie Automotive EUR 1.8B 6.22M Dec/2025
Demant DKK 10.08B 128M Dec/2025
Ence Energia y Celulosa EUR 396.7M 9.37M Mar/2026
Essilor EUR 12.01B 981M Dec/2025
Ferrovial EUR 7.31B 1.67B Dec/2025
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GRIFOLS EUR 5.25B 180M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Inditex EUR 16.09B 402M Mar/2026
Lakefront Biotherapeutics EUR 3.06B 18.72M Mar/2026
Merck EUR 14.16B 932M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Philips EUR 9.78B 148M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Smith & Nephew USD 4.63B 169M Dec/2025
UCB EUR 6.05B 733M Dec/2025
Viscofan EUR 854.65M 73.14M Mar/2026